Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
16 p, 731.1 KB The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription / Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Singh, Dave (Manchester University National Health Service Foundation Trust) ; Universitat Autònoma de Barcelona
Short-acting β agonists (SABAs) have been a mainstay of asthma treatment since the 1950s, and have been mainly recommended as-needed for symptom relief alongside daily inhaled corticosteroid (ICS)-based maintenance treatment for the past 30 years. [...]
2023 - 10.1007/s12325-022-02410-z
Advances in Therapy, Vol. 40 (january 2023) , p. 1301-1316  
2.
11 p, 2.5 MB Nebulised heparin as a treatment for COVID-19 : Scientific rationale and a call for randomised evidence / Van Haren, Frank M. P. (Intensive Care Unit. Canberra Hospital) ; Page, Clive (Sackler Institute of Pulmonary Pharmacology. King's College London) ; Laffey, John (Galway University Hospital) ; Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Camprubí-Rimblas, Marta (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Nunes, Quentin (Institute of Systems. Molecular and Integrative Biology. University of Liverpool) ; Smith, Roger (St Vincent's Hospital (Sydney)) ; Shute, Janis (School of Pharmacy and Biomedical Science. University of Portsmouth) ; Carroll, Mary (National Infection Service. Public Health England) ; Tree, Julia (National Infection Service. Public Health England) ; Carroll, Miles (National Infection Service. Public Health England) ; Singh, Dave (Medicines Evaluation Unit. University of Manchester) ; Wilkinson, Tom (Department of Respiratory Medicine. University of Southampton) ; Dixon, Barry (St Vincent's Hospital (Sydney)) ; Universitat Autònoma de Barcelona. Departament de Medicina
Nebulised unfractionated heparin (UFH) has a strong scientific and biological rationale and warrants urgent investigation of its therapeutic potential, for COVID-19-induced acute respiratory distress syndrome (ARDS). [...]
2020 - 10.1186/s13054-020-03148-2
Critical Care, Vol. 24 Núm. 1 (22 2020) , p. 454  
3.
11 p, 839.0 KB Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma / George, Leena (University of Leicester) ; Taylor, Adam R. (GSK Respiratory Therapeutic Area Unit) ; Esteve-Codina, Anna (Centre Nacional d'Anàlisi Genòmica) ; Soler Artigas, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Thun, Gian Andri (Centre Nacional d'Anàlisi Genòmica) ; Bates, Stewart (GSK Respiratory Therapeutic Area Unit) ; Pavlidis, Stelios (Imperial College London) ; Wagers, Scott (Biosci Consulting) ; Boland, Anne (CNG Centre National de Génotypage) ; Prasse, Antje (University Medical Center) ; Boschetto, Piera (University of Ferrara and Ferrara City Hospital) ; Parr, David G. (University Hospitals Coventry and Warwickshire NHS Trust) ; Nowinski, Adam (National Institute of Tuberculosis and Lung Diseases) ; Barta, Imre (National Koranyi Institute for TB and Pulmonology) ; Hohlfeld, Jens (Fraunhofer Institute for Toxicology and Experimental Medicine) ; Greulich, Timm (Member of the German Center for Lung Research (DZL)) ; van den Berge, Maarten (University of Groningen) ; Hiemstra, Pieter S. (University of Leiden) ; Timens, Wim (University of Groningen) ; Hinks, Timothy (University of Oxford) ; Wenzel, Sally (University of Pittsburgh) ; Siddiqui, Salman (University of Leicester) ; Richardson, Matthew (University of Leicester) ; Venge, Per (Uppsala University) ; Heath, Simon (Centre Nacional d'Anàlisi Genòmica) ; Gut, Ivo (Universitat Pompeu Fabra) ; Tobin, Martin D. (University of Leicester) ; Edwards, Lindsay (GSK Respiratory Therapeutic Area Unit) ; Riley, John H. (GSK Respiratory Therapeutic Area Unit) ; Djukanovic, Ratko (NIHR Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences) ; Auffray, Charles (Université de Lyon) ; De-Meulder, Bertrand (Université de Lyon) ; Erik-Dahlen, Sven (Karolinska Institutet (Estocolm, Suècia)) ; Adcock, Ian M. (Centro de Investigación Biomédica en Red de Salud Mental) ; Chung, Kian Fan (Centro de Investigación Biomédica en Red de Salud Mental) ; Ziegler-Heitbrock, Loems (Helmholtz Zentrum Muenchen and Asklepios-Klinik) ; Sterk, Peter J. (Amsterdam Universitair Medische Centra (Amsterdam, Països Baixos)) ; Singh, Dave (University Hospital of South Manchester NHS Foundation Trust) ; Brightling, Chris (University of Leicester) ; Universitat Autònoma de Barcelona
Whether the clinical or pathophysiologic significance of the "treatable trait" high blood eosinophil count in COPD is the same as for asthma remains controversial. We sought to determine the relationship between the blood eosinophil count, clinical characteristics and gene expression from bronchial brushings in COPD and asthma. [...]
2019 - 10.1111/all.14016
Allergy, Vol. 75 (september 2019) , p. 370-380  
4.
7 p, 593.4 KB Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study) / Roche, Nicolas (Respiratory Medicine, Cochin Hospital, APHP Centre University of Paris, Institut Cochin (UMR1016), Paris, France) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Backer, Vibeke (Copenhagen University. Department of Respiratory Medicine) ; van der Palen, Job (Medisch Spectrum Twente. Medical School Twente) ; Cerveri, Isa (Unit of Respiratory Diseases, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy) ; Gonzalez, Chelo (Unit of Statistics and Data Management, Experior SL, 46139 La Pobla de Farnals, Valencia, Spain) ; Safioti, Guilherme (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ; Scheepstra, Irma (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ; Patino, Oliver (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ; Singh, Dave (Centre for Respiratory Medicine and Allergy, University of Manchester, and the Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Previous studies have found suboptimal control of symptom burden to be widespread among patients with asthma and chronic obstructive pulmonary disease (COPD). The Phase IV SPRINT study was conducted in 10 countries in Europe to assess asthma disease control and COPD symptom burden in patients treated with a fixed-dose combination (FDC) of inhaled corticosteroids (ICS) and long-acting beta agonists (LABAs). [...]
2020 - 10.1038/s41533-019-0159-1
NPJ primary care respiratory medicine, Vol. 30 (january 2020)  

Vegeu també: autors amb noms similars
1 Singh, Dipti
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.